Evidence map›Paper›PMID 32296896›Full record

ArticleAbdominal radiology (New York)2020

Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy.

Iva Petkovska, Florent Tixier, Eduardo J Ortiz, Jennifer S Golia Pernicka, Viktoriya Paroder, David D Bates, Natally Horvat, James Fuqua, Juliana Schilsky, Marc J Gollub and 2 more

Open access · greenAbstract read
In one paragraph

Article in Abdominal radiology (New York), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The Role of Radiomics in Rectal Cancer.Journal of gastrointestinal cancer · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Local Recurrences in Rectal Cancer: MRI vs. CT.Diagnostics (Basel, Switzerland) · 2023
    Review
  18. Radiomics in colorectal cancer patients.World journal of gastroenterology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Iva Petkovska *Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. petkovsi@mskcc.org.ORCID http://orcid.org/0000-0002-4373-6494
Florent Tixier *Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Eduardo J OrtizDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Jennifer S Golia PernickaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Viktoriya ParoderDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
David D BatesDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Natally HorvatDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
James FuquaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Juliana SchilskyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Marc J GollubDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Julio Garcia-AguilarDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Harini VeeraraghavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Colorectal Cancer Research Center, Memorial Sloan Kettering Cancer Center CC50367NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeTo investigate the value of T2-radiomics combined with anatomical MRI staging criteria from pre-treatment rectal MRI in predicting complete response to neoadjuvant chemoradiation therapy (CRT).

methodsThis retrospective study included patients with locally advanced rectal cancer who underwent rectal MRI before neoadjuvant CRT from October 2011 to January 2015 and then surgery. Surgical histopathologic analysis was used as the reference standard for pathologic complete response. Anatomical MRI staging criteria were extracted from our institutional standardized radiology report. In radiomics analysis, one radiologist manually segmented the primary tumor on T2-weighted images for all 102 patients (i.e., training set); two different radiologists independently segmented 66/102 patients (i.e., validation set). 108 radiomics features were extracted. Then, scanner-independent features were identified and least absolute shrinkage operator analysis was used to extract a radiomics score. Finally, a support vector machine model combining the radiomics score and anatomical MRI staging criteria was compared against both anatomical MRI-only and radiomics-only models using the deLong test.

resultsThe study included 102 patients (42 women; median age = 61 years).The radiomics score produced an area under the curve (AUC) of 0.75. Comparable results were found using the validation set (AUCs = 0.75 and 0.71 for each radiologist, respectively). The anatomical MRI-only model had an accuracy of 67% (sensitivity 42%, specificity 72%); when adding the radiomics score, the accuracy increased to 74% (sensitivity 58%, specificity 77%).

conclusionCombining T2-radiomics and anatomical MRI staging criteria from pre-treatment rectal MRI may help to stratify patients based on the prediction of treatment response to neoadjuvant therapy.

Indexed as

Rectal NeoplasmsChemoradiotherapyFemaleHumansMagnetic Resonance ImagingMiddle AgedRectumRetrospective StudiesComputer-assistedImage interpretationMagnetic resonance imagingRectal cancerTreatment outcome

Identifiers

PMID32296896
PMCPMC7572430
OpenAlexW3016892711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.